Medicare+Choice CHF rates
This article was originally published in The Gray Sheet
Executive SummaryOrganizations can receive extra payments for providing out-patient care for congestive heart failure patients in 2002. CHF, one of the most frequently billed inpatient diagnoses, can often be successfully managed on an out-patient basis, according to HCFA. Payment rates for Medicare+Choice plans will increase by 5.3% next year
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.